Natural history of nonalcoholic fatty liver disease: A prospective follow-up study with serial biopsies.

scientific article

Natural history of nonalcoholic fatty liver disease: A prospective follow-up study with serial biopsies. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/HEP4.1134
P932PMC publication ID5796332
P698PubMed publication ID29404527

P50authorPatrik NasrQ86587781
P2093author name stringMattias Ekstedt
Stergios Kechagias
Simone Ignatova
P2860cites workLiver fibrosis in overweight patientsQ28145482
Nonalcoholic fatty liver disease: a feature of the metabolic syndromeQ28208772
The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification TestQ28282539
Design and validation of a histological scoring system for nonalcoholic fatty liver diseaseQ29614930
The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological AssociationQ29617157
The natural history of nonalcoholic fatty liver disease: a population-based cohort studyQ29617161
Long-term follow-up of patients with NAFLD and elevated liver enzymesQ29620024
Transient elastography: a new noninvasive method for assessment of hepatic fibrosis.Q34544284
Non-alcoholic steatohepatitis: a common cause of progressive chronic liver injury?Q34795935
Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver DiseaseQ35893923
Nonalcoholic fatty liver disease: from steatosis to cirrhosisQ36382279
Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver DiseaseQ37794163
A systematic review of follow-up biopsies reveals disease progression in patients with non-alcoholic fatty liverQ38105838
Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studiesQ38207382
Decreased survival of subjects with elevated liver function tests during a 28-year follow-up.Q38447369
Nonalcoholic steatohepatitis: a study of 49 patientsQ38632482
Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes.Q38680300
Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis.Q39745120
Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD.Q40084558
The natural history of nonalcoholic fatty liver: a follow-up studyQ40376691
Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United StatesQ41626076
Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implications for prognosis and clinical managementQ41725283
Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-upQ42201783
Cirrhosis in hepatitis C virus-infected patients can be excluded using an index of standard biochemical serum markersQ42994550
A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C.Q44527614
Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfectionQ44920531
The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 yearsQ45787554
The natural history of nonalcoholic fatty liver disease: a clinical histopathological studyQ47617617
Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease.Q51707737
Sampling Variability of Liver Biopsy in Nonalcoholic Fatty Liver DiseaseQ58622754
The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLDQ61989968
Natural history of nonalcoholic steatohepatitis: a longitudinal study of repeat liver biopsiesQ80594561
Histological progression of non-alcoholic fatty liver disease in Chinese patientsQ81399582
Final results of a long-term, clinical follow-up in fatty liver patientsQ84384267
Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 yearsQ84484058
P433issue2
P921main subjectbiopsyQ179991
metabolic dysfunction–associated steatotic liver diseaseQ1546498
fatty liver diseaseQ6058862
P304page(s)199-210
P577publication date2017-12-27
P1433published inHepatology CommunicationsQ50817751
P1476titleNatural history of nonalcoholic fatty liver disease: A prospective follow-up study with serial biopsies
P478volume2

Reverse relations

cites work (P2860)
Q64064053Association between ADIPOQ G276T and C11377G polymorphisms and the risk of non-alcoholic fatty liver disease: An updated meta-analysis
Q90838502CON: This Patient Should Have a Noninvasive Assessment of Liver Staging
Q60923925Childhood Fructoholism and Fructoholic Liver Disease
Q60910136Current status, problems, and perspectives of non-alcoholic fatty liver disease research
Q98945558Evaluating the Therapeutic Potential of Cenicriviroc in the Treatment of Nonalcoholic Steatohepatitis with Fibrosis: A Brief Report on Emerging Data
Q92694745From sugar to liver fat and public health: systems biology driven studies in understanding non-alcoholic fatty liver disease pathogenesis
Q64252579Glucagon-Induced Acetylation of Energy-Sensing Factors in Control of Hepatic Metabolism
Q91966496Hepatocyte Deletion of Triglyceride-Synthesis Enzyme Acyl CoA: Diacylglycerol Acyltransferase 2 Reduces Steatosis Without Increasing Inflammation or Fibrosis in Mice
Q61808847Identifying and Treating Nonalcoholic Fatty Liver Disease
Q89848872Serum Golgi Protein 73 as a Potential Biomarker for Hepatic Necroinflammation in Population with Nonalcoholic Steatohepatitis

Search more.